Navigation Links
Takeda and Zinfandel Pharmaceuticals Initiate Phase 3 TOMMORROW Trial of AD-4833 for the Delay of Onset of Mild Cognitive Impairment Due to Alzheimer's Disease in Subjects Selected Using a Genetic-Based Biomarker Risk Assignment Algorithm
Date:8/26/2013

p="name">Stephen Brannan, M.D., Central Nervous System Development Therapeutic Area Head, Takeda. "TOMMORROW is a significant study and represents a novel clinical milestone and trial for the Alzheimer's community as it evaluates pre-symptomatic patients."

About the TOMMORROW Trial
The TOMMORROW trial is a global, multicenter, randomized, double-blind, placebo-controlled, parallel-group study. The trial will use a genetic–based biomarker risk assignment algorithm comprised of APOE and TOMM40 genotypes and age, which is being studied to determine the risk of individuals developing MCI due to AD within a five year period. Cognitively normal individuals assessed as low risk will be assigned to receive placebo. Cognitively normal individuals assessed as high risk will be assigned to AD-4833 or placebo. The study duration is approximately five years or the time needed to achieve 410 conversions to MCI due to AD in the high risk group. Approximately 5,800 cognitively normal individuals aged 65-83 at 50 centers worldwide will be randomized into the study. The study will recruit internationally from large, diverse, community-based populations.

The study has two objectives:

For the genetic-based biomarker risk assignment algorithm, the primary objective is to qualify the risk assignment algorithm for identification of subjects at high risk of developing MCI due to AD within the next five years. The primary endpoint for the risk assignment algorithm is time to diagnosis of MCI due to AD for placebo-treated, high-risk subjects versus placebo-treated, low-risk subjects.

For AD-4833, considered an investigational drug for this use, the primary objective is to evaluate the efficacy of AD-4833 versus placebo in delaying the onset of MCI due to AD in cognitively normal individuals assessed as high risk based on the risk assignment algorithm. The primary endpoint is time to diagnosis of MCI due to AD for AD-4833-treated subjects versus pl
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Takeda Launches New Subsidiary in Peru
2. Data Published in the New England Journal of Medicine for Vedolizumab, an Investigational New Drug from Takeda for Moderately to Severely Active Ulcerative Colitis and Crohns Disease
3. Among New Agents Entering the Unipolar Depression Market Over the Next Decade, Lundbeck/Takeda Pharmaceuticals Brintellix Has Blockbuster Potential
4. Takeda Submits Biologics License Application for a New Investigational Drug Vedolizumab, in Moderately to Severely Active Crohns Disease and Ulcerative Colitis in the United States
5. Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
6. AGA Research Foundation Announces Endowment Gift from Takeda Pharmaceuticals U.S.A., Inc. to Support Gastroenterology Research
7. Takeda to Acquire Inviragen, Inc.
8. Takeda Responds to Verdict in Diabetes Drug Case
9. Takeda Launches New Subsidiary in Ecuador
10. Takeda lanza nueva subsidiaria en Ecuador
11. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... Research and Markets has announced ... Market & Pipeline Insight 2014" report to their ... prevent and eradicate the prevalence of cancer have achieved ... to low specificity, safety and large number of side ... better solution. It has been discovered that peptides can ...
(Date:8/29/2014)... , Aug. 29, 2014 Research ... "Research and Development Trend Forecast of Pharmaceutical Equipment ... Research and Development Trend Forecast of ... 2014-2018 mainly analyzes China,s pharmaceutical ... supply & demand, competition landscape, and business performance of ...
(Date:8/29/2014)... Diseases largely eradicated in the United States ... declared eliminated in 2000, yet the CDC reports 593 ... incidence in 20 years. In July, California,s ... problem of "epidemic proportions." Across ... preventable diseases—in part because some parents (more than 10 ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3
... DIEGO, April 27 The Villa Group is closely monitoring ... all appropriate steps to ensure the safety and health of ... resort properties (located in Cabo San Lucas, Puerto Vallarta, and ... where the outbreaks have occurred. No cases have been reported ...
... Men taking generic drugs may be more likely ... than if they were using branded medications, according to ... a study at the 104th Annual Scientific Meeting of ... for alpha blockers and 5-alpha reductase inhibitors (5-ARIs), two ...
Cached Medicine Technology:The Villa Group Informs on Mexico Travel Plans in Wake of Swine Flu Outbreak 2Generic Substitutes Less Effective/Safe Than Branded Medications in Treating Lower Urinary Tract Symptoms 2
(Date:8/29/2014)... August 29, 2014 Formed in 2014, KAJ ... well beyond their years. Their sophisticated Pop/R&B sound, with ... listener is fortunate enough to experience every day. ... audience uplifted and feeling loved with the primary purpose of ... about this, the group unanimously replied - “To make chivalry ...
(Date:8/29/2014)... Los Angeles, CA (PRWEB) August 29, 2014 ... patients with late stages of hair loss achieve great results ... as the Facial Hair Transplant , an FUE method ... or recipient area. This method lets patients whose hair ... their head. Facial Hair Transplant is a great alternative for ...
(Date:8/29/2014)... SC (PRWEB) August 29, 2014 Highly regarded ... reports on important hearing health topics. The four reports are titled:, ... The Secrets to Hearing Aid Success , The ... , Understanding Auditory Processing Disorder in Children ... topics because there is a lot of confusion and misinformation about ...
(Date:8/29/2014)... IL (PRWEB) August 29, 2014 Pursuing ... is set to unveil a stunning new design ... to company figures, the highly notable surrogacy platform has ... January. With over 13,000 visitors a month, the FindSurrogateMother.com ... mothers working toward one common goal — the precious ...
(Date:8/29/2014)... News) -- If you have bunions, taking care of them ... expert says. A bunion is a bump that forms ... tissue moves out of place and extends beyond the normal ... pain and may require surgery to correct, said Brent Rosenthal, ... Freehold, N.J. To prevent bunions, avoid wearing shoes with ...
Breaking Medicine News(10 mins):Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 2Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 4Health News:Advanced Hair Loss Patients Can Now Qualify for Hair Transplants Using Facial Donor Hair 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 2Health News:Charleston SC Audiologist, Dr. Mary Ann Larkin Authors Four New Special Reports on Important Hearing Healthcare Topics 3Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 2Health News:FindSurrogateMother.com Set to Unveil Stunning New Design as Member Sign-ups Increase by 42% since January 3Health News:Take Steps to Control Bunions 2
... team of Texas AgriLife Research engineers has developed a way ... irradiation needed to kill 99.999 percent of salmonella, E. ... packing produce in a Mylar bag filled with pure oxygen, ... colleagues found they could significantly reduce the amount of radiation ...
... a clear link between accepting family attitudes and ... (LGBT) children and significantly decreased risk and better ... specific parental and caregiver behaviors -- such as ... because of their LGBT identity or supporting their ...
... FRIDAY, Dec. 3 (HealthDay News) -- Although winter hasn,t even ... officials said Friday. In fact, Georgia is seeing a ... the state calling it a regional outbreak. The Georgia cases ... the rest of the country once flu season really gets ...
... FRIDAY, Dec. 3 (HealthDay News) -- Education and rule ... players, but wearing protective equipment such as headgear and ... review. Canadian researchers came to that conclusion after ... spinal cord injuries in rugby players, including six that ...
... Spanish Oncology has established a new standard treatment for ... of the study 9805/Target 0 funded by Spanish Breast ... More than thousand patients and 50 hospitals ... the latest issue of The New England Journal of ...
... FRIDAY, Dec. 3 (HealthDay News) -- The impending extinction ... remove an important buffer against the transmission of infectious ... by the U.S. National Science Foundation and National Institutes ... the U.S. Environmental Protection Agency, focused on how the ...
Cached Medicine News:Health News:AgriLife researchers find way to cut food-irradiation levels by half 2Health News:AgriLife researchers find way to cut food-irradiation levels by half 3Health News:AgriLife researchers find way to cut food-irradiation levels by half 4Health News:Study finds family acceptance of LGBT youth protects against depression, substance abuse, suicide 2Health News:Study finds family acceptance of LGBT youth protects against depression, substance abuse, suicide 3Health News:Study finds family acceptance of LGBT youth protects against depression, substance abuse, suicide 4Health News:Outbreaks Signal Another Flu Season, CDC Says 2Health News:Outbreaks Signal Another Flu Season, CDC Says 3Health News:Spanish Oncology to establish a new standard treatment on breast cancer at early stages 2Health News:Spanish Oncology to establish a new standard treatment on breast cancer at early stages 3Health News:Species Extinctions May Spell Trouble for Human Health 2
The DFS Standard Fixator advantages include a highly adjustable system, modular compression/distraction, versatile central body component that provides 360 of rotation, and a positive locking mechani...
... II Compact™ Upper extremity fixator has been ... distal radius by allowing independent movement of ... the main goals has been to reduce ... versatility and ease of use. The Hoffmann® ...
The Medium External Fixator has a medium Combination Clamp that connects rod to rod or pin to rod as well as a Medium Multi-Pin Clamp that connects pins to rods allowing parallel pin placement....
The DFS MiniFixator is a lightweight, external device for the treatment of small bone fractures and osteotomies....
Medicine Products: